{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T09:04:12Z","timestamp":1794733452494,"version":"4.9.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":320,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1186\/s13613-025-01434-2","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T21:55:57Z","timestamp":1737064557000},"page":"12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implications"],"prefix":"10.1016","volume":"15","author":[{"given":"Ana\u00efs","family":"Curtiaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Iba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Angles-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat","family":"Meziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0895-6800","authenticated-orcid":false,"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1186\/s13613-025-01434-2_bb0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00134-023-06980-6","article-title":"How to manage coagulopathies in critically ill patients","volume":"49","author":"Helms","year":"2023","journal-title":"Intensive Care Med mars"},{"key":"10.1186\/s13613-025-01434-2_bb0015","doi-asserted-by":"crossref","unstructured":"Girardis M, David S, Ferrer R, Helms J, Juffermans NP, Martin-Loeches I et al. Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis. Intensive Care Med 2 sept 2024 [cit\u00e9 9 sept 2024]; Disponible sur: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00134-024-07586-2","DOI":"10.1007\/s00134-024-07586-2"},{"key":"10.1186\/s13613-025-01434-2_bb0020","unstructured":"Warren BL, Eid A, Singer P, Pillay SS. High-Dose Antithrombin III in Severe Sepsis."},{"issue":"6","key":"10.1186\/s13613-025-01434-2_bb0025","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00134-003-1731-1","article-title":"Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial","volume":"29","author":"Dhainaut, Dhainaut","year":"2003","journal-title":"Intensive Care Med juin"},{"issue":"10","key":"10.1186\/s13613-025-01434-2_bb0030","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00134-013-2993-x","article-title":"Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy","volume":"39","author":"Delabranche","year":"2013","journal-title":"Intensive Care Med oct"},{"issue":"11","key":"10.1186\/s13613-025-01434-2_bb0035","doi-asserted-by":"crossref","first-page":"e1132","DOI":"10.1097\/CCM.0000000000001851","article-title":"Neutrophil fluorescence: a New Indicator of Cell Activation during septic shock\u2013Induced disseminated Intravascular Coagulation","volume":"44","author":"Stiel","year":"2016","journal-title":"Crit Care Med Nov"},{"issue":"8","key":"10.1186\/s13613-025-01434-2_bb0040","first-page":"2605","article-title":"Directing thrombin","volume":"106","author":"Lane","year":"2005","journal-title":"Blood 15 oct"},{"issue":"3","key":"10.1186\/s13613-025-01434-2_bb0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jth.13235","article-title":"Contact system revisited: an interface between inflammation, coagulation, and innate immunity","volume":"14","author":"Long","year":"2016","journal-title":"J Thromb Haemostasis mars"},{"issue":"1","key":"10.1186\/s13613-025-01434-2_bb0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J Thromb Haemostasis janv"},{"issue":"4","key":"10.1186\/s13613-025-01434-2_bb0055","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jth.13625","article-title":"Thrombin contributes to protective immunity in pneumonia-derived sepsis via fibrin polymerization and platelet\u2013neutrophil interactions","volume":"15","author":"Claushuis","year":"2017","journal-title":"J Thromb Haemostasis avr"},{"key":"10.1186\/s13613-025-01434-2_bb0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13613-017-0339-5","article-title":"Immunohaemostasis: a new view on haemostasis during sepsis","volume":"7","author":"Delabranche","year":"2017","journal-title":"Ann Intensive Care 2 d\u00e9c"},{"issue":"8","key":"10.1186\/s13613-025-01434-2_bb0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.medmal.2012.05.011","article-title":"Microparticles and infectious diseases","volume":"42","author":"Delabranche","year":"2012","journal-title":"M\u00e9decine et Maladies Infectieuses ao\u00fbt"},{"issue":"10","key":"10.1186\/s13613-025-01434-2_bb0070","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00134-013-3054-1","article-title":"Endothelial injury in sepsis","volume":"39","author":"Levi","year":"2013","journal-title":"Intensive Care Med oct"},{"issue":"1","key":"10.1186\/s13613-025-01434-2_bb0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol Janv"},{"issue":"12","key":"10.1186\/s13613-025-01434-2_bb0080","doi-asserted-by":"crossref","first-page":"14270","DOI":"10.1096\/fj.201901363RRR","article-title":"DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma","volume":"33","author":"Cruz","year":"2019","journal-title":"FASEB J d\u00e9c"},{"issue":"10","key":"10.1186\/s13613-025-01434-2_bb0085","doi-asserted-by":"crossref","first-page":"e930","DOI":"10.1097\/CCM.0000000000001836","article-title":"Early detection of disseminated intravascular coagulation during septic shock: a Multicenter prospective study","volume":"44","author":"Delabranche","year":"2016","journal-title":"Crit Care Med oct"},{"issue":"11","key":"10.1186\/s13613-025-01434-2_bb0090","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1186\/s13613-025-01434-2_bb0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","article-title":"A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria*","volume":"34","author":"Gando","year":"2006","journal-title":"Crit Care Med mars"},{"key":"10.1186\/s13613-025-01434-2_bb0100","unstructured":"Asakura H, Ontachi Y, Mizutani T, Kato M, Ito T, Saito M et al. Depressed plasma activity of plasminogen or \u00e12 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation."},{"issue":"4","key":"10.1186\/s13613-025-01434-2_bb0105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/CCM.0000000000001520","article-title":"Is Thrombocytopenia an early prognostic marker in septic shock?","volume":"44","author":"Thiery-Antier","year":"2016","journal-title":"Crit Care Med avr"},{"issue":"7","key":"10.1186\/s13613-025-01434-2_bb0110","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00134-024-07478-5","article-title":"Ten tips on sepsis-induced thrombocytopenia","volume":"50","author":"Leone","year":"2024","journal-title":"Intensive Care Med Juill"},{"key":"10.1186\/s13613-025-01434-2_bb0115","doi-asserted-by":"crossref","unstructured":"Greco E, Lupia E, Bosco O, Vizio B, Montrucchio G. Platelets and multi-organ failure in Sepsis. IJMS. oct 2017;20(10):2200.","DOI":"10.3390\/ijms18102200"},{"key":"10.1186\/s13613-025-01434-2_bb0120","unstructured":"Becchi C, Al Malyan M, Fabbri LP, Marsili M, Boddi V, Boncinelli S. (2006) Mean platelet volume trend in sepsis: is it a useful parameter? Minerva Anestesiol 72: 749\u2013756. [cit\u00e9 3 sept 2024]. Disponible sur: https:\/\/www.minervamedica.it\/en\/getfreepdf\/eE1rOU81a0RLMk5DejNTVG1ubzBTUkhnc2pDWGtjcy8yYzN5NEpKSHFVQW13dk52WTc2ZE9TWnU1RlB4ZDd5dQ%253D%253D\/R02Y2006N09A0749.pdf"},{"issue":"8","key":"10.1186\/s13613-025-01434-2_bb0125","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s00134-024-07507-3","article-title":"Sepsis-induced coagulopathy: a matter of timeline","volume":"50","author":"Meziani","year":"2024","journal-title":"Intensive Care Med ao\u00fbt"},{"issue":"8","key":"10.1186\/s13613-025-01434-2_bb0130","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/jth.14482","article-title":"Proposal of a two-step process for the diagnosis of sepsis\u2010induced disseminated intravascular coagulation","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemostasis ao\u00fbt"},{"issue":"1","key":"10.1186\/s13613-025-01434-2_bb0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jtha.2022.10.022","article-title":"Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis","volume":"21","author":"Iba","year":"2023","journal-title":"J Thromb Haemost janv"},{"issue":"3","key":"10.1186\/s13613-025-01434-2_bb0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/107602960300900308","article-title":"Increased Soluble Fibrin in plasma of patients with disseminated intravascular coagulation","volume":"9","author":"Wada","year":"2003","journal-title":"Clin Appl Thromb Hemost Juill"},{"issue":"7","key":"10.1186\/s13613-025-01434-2_bb0145","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1177\/1076029618762473","article-title":"Clinical Investigation of Coagulation Markers for Early Detection of Sepsis-Induced disseminated intravascular coagulation: a Single-Center, prospective observational study","volume":"24","author":"Masuda","year":"2018","journal-title":"Clin Appl Thromb Hemost oct"},{"issue":"3","key":"10.1186\/s13613-025-01434-2_bb0150","first-page":"143","article-title":"Evaluation of the diagnostic performance of Fibrin Monomer in disseminated intravascular coagulation","volume":"31","author":"Park","year":"2011","journal-title":"Korean J Lab Med Juill"},{"issue":"1","key":"10.1186\/s13613-025-01434-2_bb0155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2007.07.023","article-title":"Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis","volume":"386","author":"Ieko","year":"2007","journal-title":"Clin Chim Acta 1 nov"},{"issue":"1","key":"10.1186\/s13613-025-01434-2_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(01)00331-0","article-title":"Activity and Antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation","volume":"104","author":"Watanabe","year":"2001","journal-title":"Thromb Res oct"},{"issue":"6","key":"10.1186\/s13613-025-01434-2_bb0165","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1538-7836.2006.01942.x","article-title":"Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis","volume":"4","author":"Wada","year":"2006","journal-title":"J Thromb Haemostasis juin"},{"key":"10.1186\/s13613-025-01434-2_bb0170","doi-asserted-by":"crossref","unstructured":"Zhang J, Xue M, Chen Y, Liu C, Kuang Z, Mu S, et al. Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation. Ann Palliat Med. oct 2021;10(10):10170\u201384.","DOI":"10.21037\/apm-21-2222"},{"issue":"6","key":"10.1186\/s13613-025-01434-2_bb0175","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.thromres.2013.09.033","article-title":"Age- and sex-dependent reference intervals for D-dimer: evidence for a marked increase by age","volume":"132","author":"Haase","year":"2013","journal-title":"Thromb Res d\u00e9c"},{"key":"10.1186\/s13613-025-01434-2_bb0180","unstructured":"Borschneck C, Dreyfus M, Bridey F, Edouard D, Meyer D. [Assay of products of fibrin and fibrinogen degradation in disseminated intravascular coagulations. Evaluation of a new technique]. Presse Med. 6 mai 1995;24(17):799\u2013802."},{"key":"10.1186\/s13613-025-01434-2_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2000-9797","article-title":"Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers","volume":"26","author":"Wada","year":"2000","journal-title":"Seminars Thromb Hemost 31 d\u00e9c"},{"issue":"2","key":"10.1186\/s13613-025-01434-2_bb0190","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.thromres.2011.02.015","article-title":"Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases","volume":"128","author":"Kawasugi","year":"2011","journal-title":"Thromb Res ao\u00fbt"},{"issue":"1","key":"10.1186\/s13613-025-01434-2_bb0195","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/cc13190","article-title":"Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study","volume":"18","author":"Koyama","year":"2014","journal-title":"Crit Care"},{"key":"10.1186\/s13613-025-01434-2_bb0200","unstructured":"Study of the balance. between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Asakura Blood 1994."},{"issue":"28","key":"10.1186\/s13613-025-01434-2_bb0205","doi-asserted-by":"crossref","first-page":"16603","DOI":"10.1074\/jbc.271.28.16603","article-title":"Couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex","volume":"271","author":"Bajzar","year":"1996","journal-title":"J Biol Chem Juill"},{"key":"10.1186\/s13613-025-01434-2_bb0210","doi-asserted-by":"crossref","unstructured":"Sillen M, Declerck PJ. Thrombin activatable fibrinolysis inhibitor (TAFI): an updated narrative review. Int J Mol Sci. 2021;22(7):3670.","DOI":"10.3390\/ijms22073670"},{"issue":"2","key":"10.1186\/s13613-025-01434-2_bb0215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1538-7836.2008.02841.x","article-title":"Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children","volume":"6","author":"Emonts","year":"2008","journal-title":"J Thromb Haemostasis f\u00e9vr"},{"issue":"2","key":"10.1186\/s13613-025-01434-2_bb0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.thromres.2005.06.007","article-title":"TAFI and PAI-1 levels in human sepsis","volume":"118","author":"Zeerleder","year":"2006","journal-title":"Thromb Res janv"},{"issue":"10","key":"10.1186\/s13613-025-01434-2_bb0225","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00277-005-1079-4","article-title":"Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation","volume":"84","author":"Chen","year":"2005","journal-title":"Ann Hematol oct"},{"issue":"12","key":"10.1186\/s13613-025-01434-2_bb0230","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/ATVBAHA.115.306035","article-title":"Cell-free DNA modulates clot structure and impairs Fibrinolysis in Sepsis","volume":"35","author":"Gould","year":"2015","journal-title":"ATVB d\u00e9c"},{"issue":"01","key":"10.1186\/s13613-025-01434-2_bb0235","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1160\/TH10-05-0293","article-title":"Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation","volume":"105","author":"Takemitsu","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1186\/s13613-025-01434-2_bb0240","doi-asserted-by":"crossref","unstructured":"Choi Q, Hong KH, Kim JE, Kim HK. Changes in Plasma Levels of Natural Anticoagulants in Disseminated Intravascular Coagulation: High Prognostic Value of Antithrombin and Protein C in Patients with Underlying Sepsis or Severe Infection. Ann Lab Med. 1 mars. 2014;34(2):85\u201391.","DOI":"10.3343\/alm.2014.34.2.85"},{"issue":"Supplement 1","key":"10.1186\/s13613-025-01434-2_bb0245","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1182\/blood-2023-178993","article-title":"The proactive diagnostic value of Thrombin-Antithrombin Complex and Antithrombin III in disseminated intravascular coagulation","volume":"142","author":"Guo","year":"2023","journal-title":"Blood 2 nov"},{"issue":"1","key":"10.1186\/s13613-025-01434-2_bb0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13054-016-1468-1","article-title":"Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity","volume":"20","author":"Iba","year":"2016","journal-title":"Crit Care d\u00e9c"},{"issue":"5","key":"10.1186\/s13613-025-01434-2_bb0255","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0037-1613883","article-title":"The endothelial cell protein C receptor","volume":"83","author":"Esmon","year":"2000","journal-title":"Thromb Haemost Mai"},{"issue":"1","key":"10.1186\/s13613-025-01434-2_bb0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-0038-1657503","article-title":"The protein C pathway: new insights","volume":"78","author":"Esmon","year":"1997","journal-title":"Thromb Haemost Juill"},{"issue":"3\u20134","key":"10.1186\/s13613-025-01434-2_bb0265","first-page":"118","article-title":"High Macrophage Migration Inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation","volume":"30","author":"Gando","year":"2007","journal-title":"Inflamm 21 juin"},{"issue":"3","key":"10.1186\/s13613-025-01434-2_bb0270","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/CCM.0B013E31816537D8","article-title":"Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis*","volume":"36","author":"Lin","year":"2008","journal-title":"Crit Care Med mars"},{"issue":"5","key":"10.1186\/s13613-025-01434-2_bb0275","article-title":"Preliminary study of microparticle coagulation properties in septic patients with disseminated intravascular coagulation","volume":"49","author":"Meng","year":"2021","journal-title":"J Int Med Res 25 mai"},{"issue":"8","key":"10.1186\/s13613-025-01434-2_bb0280","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1177\/1076029618786029","article-title":"Angiopoietin 2 levels in the risk stratification and mortality outcome prediction of Sepsis-Associated Coagulopathy","volume":"24","author":"Statz","year":"2018","journal-title":"Clin Appl Thromb Hemost Nov"},{"issue":"2","key":"10.1186\/s13613-025-01434-2_bb0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.thromres.2004.09.022","article-title":"Serial changes in neutrophil\u2013endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation","volume":"116","author":"Gando","year":"2005","journal-title":"Thromb Res janv"},{"issue":"Supplement","key":"10.1186\/s13613-025-01434-2_bb0290","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.1097\/00003246-200205001-00021","article-title":"Markers of endothelial damage in organ dysfunction and sepsis","volume":"30","author":"Reinhart","year":"2002","journal-title":"Crit Care Med Mai"},{"key":"10.1186\/s13613-025-01434-2_bb0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.thromres.2019.09.036","article-title":"First visualization of circulating neutrophil extracellular traps using cell fluorescence during human septic shock-induced disseminated intravascular coagulation","volume":"183","author":"Stiel","year":"2019","journal-title":"Thromb Res Nov"},{"issue":"2","key":"10.1186\/s13613-025-01434-2_bb0300","doi-asserted-by":"crossref","first-page":"114","DOI":"10.14789\/jmj.JMJ23-0044-P","article-title":"The detection of Neutrophil activation by automated blood cell counter in Sepsis","volume":"70","author":"Helms","year":"2024","journal-title":"Juntendo Med J"},{"key":"10.1186\/s13613-025-01434-2_bb0305","doi-asserted-by":"crossref","unstructured":"Iba T, Helms J, Levy JH. Sepsis-induced coagulopathy (SIC) in the management of sepsis. Ann Intensive Care. sept 2024;20(1):148.","DOI":"10.1186\/s13613-024-01380-5"},{"issue":"3","key":"10.1186\/s13613-025-01434-2_bb0310","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/CCM.0000000000000763","article-title":"The efficacy and safety of heparin in patients with Sepsis: a systematic review and Metaanalysis*","volume":"43","author":"Zarychanski","year":"2015","journal-title":"Crit Care Med mars"},{"key":"10.1186\/s13613-025-01434-2_bb0315","doi-asserted-by":"crossref","first-page":"1173893","DOI":"10.3389\/fphar.2023.1173893","article-title":"Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy","volume":"14","author":"Huang","year":"2023","journal-title":"Front Pharmacol 15 mai"},{"key":"10.1186\/s13613-025-01434-2_bb0320","doi-asserted-by":"crossref","first-page":"109095","DOI":"10.1016\/j.thromres.2024.109095","article-title":"Efficacy of unfractionated heparin in patients with moderate sepsis-induced coagulopathy: an observational study","volume":"241","author":"Ushio","year":"2024","journal-title":"Thromb Res sept"},{"issue":"4","key":"10.1186\/s13613-025-01434-2_bb0325","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00134-016-4225-7","article-title":"Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis","volume":"42","author":"Allingstrup","year":"2016","journal-title":"Intensive Care Med avr"},{"key":"10.1186\/s13613-025-01434-2_bb0330","doi-asserted-by":"crossref","unstructured":"Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S et al. Drotrecogin Alfa (Activated) in Adults with Septic Shock. N Engl J Med. 31 mai. 2012;366(22):2055\u201364.","DOI":"10.1056\/NEJMoa1202290"},{"key":"10.1186\/s13613-025-01434-2_bb0335","doi-asserted-by":"crossref","unstructured":"Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY et al. Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial. JAMA. 28 mai. 2019;321(20):1993.","DOI":"10.1001\/jama.2019.5358"},{"issue":"1","key":"10.1186\/s13613-025-01434-2_bb0340","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13613-021-00842-4","article-title":"Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET","volume":"11","author":"Fran\u00e7ois","year":"2021","journal-title":"Ann Intensive Care d\u00e9c"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-025-01434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-025-01434-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-025-01434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:56:03Z","timestamp":1776671763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"alternative-id":["S2110582025000251"],"URL":"https:\/\/doi.org\/10.1186\/s13613-025-01434-2","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-025-01434-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025 The Author(s) 2025. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"12"}}